Literature DB >> 18667814

Oral anticoagulation in patients with cardiomyopathy or heart failure in sinus rhythm.

P Pullicino1, J L P Thompson, J P Mohr, R L Sacco, R Freudenberger, B Levin, S Homma.   

Abstract

BACKGROUND: Despite many prospective randomized studies defining the benefits of anticoagulation in atrial fibrillation (AF), there have been no adequate studies in cardiomyopathy (CM) in sinus rhythm.
METHODS: We review the current knowledge of the risk of stroke in CM, left ventricular systolic dysfunction and heart failure as well as the indications for antithrombotic agents and compare this with AF.
RESULTS: The current knowledge of risk factors for stroke and indications for antithrombotic agents in CM is similar to that of AF prior to the treatment studies of the 1980s-1990s.
CONCLUSION: Prospective randomized trial data are urgently needed to determine the role of antithrombotic drugs in CM. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18667814     DOI: 10.1159/000149581

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  6 in total

1.  Identifying a high stroke risk subgroup in individuals with heart failure.

Authors:  Patrick M Pullicino; Leslie A McClure; Virginia J Howard; Virginia G Wadley; Monika M Safford; James F Meschia; Aaron Anderson; George Howard; Elsayed Z Soliman
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-12-03       Impact factor: 2.136

Review 2.  [Neurological aspects of chronic heart failure].

Authors:  K G Häusler; U Laufs; M Endres
Journal:  Nervenarzt       Date:  2011-06       Impact factor: 1.214

3.  Blood pressure and stroke in heart failure in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Authors:  Patrick M Pullicino; Leslie A McClure; Virginia G Wadley; Ali Ahmed; Virginia J Howard; George Howard; Monika M Safford
Journal:  Stroke       Date:  2009-10-15       Impact factor: 7.914

4.  Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial.

Authors:  Patrick M Pullicino; John L P Thompson; Ralph L Sacco; Alexandra R Sanford; Min Qian; John R Teerlink; Haissam Haddad; Monika Diek; Ronald S Freudenberger; Arthur J Labovitz; Marco R Di Tullio; Dirk J Lok; Piotr Ponikowski; Stefan D Anker; Susan Graham; Douglas L Mann; J P Mohr; Shunichi Homma
Journal:  Cerebrovasc Dis       Date:  2013-07-30       Impact factor: 2.762

5.  Heart failure in acute ischemic stroke.

Authors:  Elisa Cuadrado-Godia; Angel Ois; Jaume Roquer
Journal:  Curr Cardiol Rev       Date:  2010-08

6.  Clinical characteristics, precipitating factors, management and outcome of patients with prior stroke hospitalised with heart failure: an observational report from the Middle East.

Authors:  Hadi A R Khafaji; Kadhim Sulaiman; Rajvir Singh; Khalid F AlHabib; Nidal Asaad; Alawi Alsheikh-Ali; Mohammed Al-Jarallah; Bassam Bulbanat; Wael AlMahmeed; Mustafa Ridha; Nooshin Bazargani; Haitham Amin; Ahmed Al-Motarreb; Hussam AlFaleh; Abdelfatah Elasfar; Prashanth Panduranga; Jassim Al Suwaidi
Journal:  BMJ Open       Date:  2015-04-23       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.